Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Farmalider refers to a portfolio of analgesic and antipyretic medications developed by Farmalider S.A., a Spanish pharmaceutical company specializing in the development and licensing of generic and value-added drug products. The product line primarily includes formulations of ibuprofen and paracetamol (acetaminophen), which are indicated for the treatment of mild to moderate pain, fever, and inflammation. These active ingredients work by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins that mediate pain and inflammatory responses. Farmalider is known for its diverse range of dosage forms, including oral solutions, tablets, and sachets, many of which are licensed to other pharmaceutical companies for global distribution. The company was acquired by Aurobindo Pharma in 2014, which now oversees its manufacturing and commercialization efforts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Farmalider.